ID FBSP1_HUMAN Reviewed; 286 AA. AC P0C2W1; A6NF90; D3DXB5; DT 01-MAY-2007, integrated into UniProtKB/Swiss-Prot. DT 01-MAY-2007, sequence version 1. DT 05-FEB-2025, entry version 144. DE RecName: Full=F-box/SPRY domain-containing protein 1; DE AltName: Full=F-box only protein 45; DE Short=hFbxo45; GN Name=FBXO45; Synonyms=FBX45; OS Homo sapiens (Human). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae; OC Homo. OX NCBI_TaxID=9606; RN [1] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RX PubMed=16641997; DOI=10.1038/nature04728; RA Muzny D.M., Scherer S.E., Kaul R., Wang J., Yu J., Sudbrak R., Buhay C.J., RA Chen R., Cree A., Ding Y., Dugan-Rocha S., Gill R., Gunaratne P., RA Harris R.A., Hawes A.C., Hernandez J., Hodgson A.V., Hume J., Jackson A., RA Khan Z.M., Kovar-Smith C., Lewis L.R., Lozado R.J., Metzker M.L., RA Milosavljevic A., Miner G.R., Morgan M.B., Nazareth L.V., Scott G., RA Sodergren E., Song X.-Z., Steffen D., Wei S., Wheeler D.A., Wright M.W., RA Worley K.C., Yuan Y., Zhang Z., Adams C.Q., Ansari-Lari M.A., Ayele M., RA Brown M.J., Chen G., Chen Z., Clendenning J., Clerc-Blankenburg K.P., RA Chen R., Chen Z., Davis C., Delgado O., Dinh H.H., Dong W., Draper H., RA Ernst S., Fu G., Gonzalez-Garay M.L., Garcia D.K., Gillett W., Gu J., RA Hao B., Haugen E., Havlak P., He X., Hennig S., Hu S., Huang W., RA Jackson L.R., Jacob L.S., Kelly S.H., Kube M., Levy R., Li Z., Liu B., RA Liu J., Liu W., Lu J., Maheshwari M., Nguyen B.-V., Okwuonu G.O., RA Palmeiri A., Pasternak S., Perez L.M., Phelps K.A., Plopper F.J., Qiang B., RA Raymond C., Rodriguez R., Saenphimmachak C., Santibanez J., Shen H., RA Shen Y., Subramanian S., Tabor P.E., Verduzco D., Waldron L., Wang J., RA Wang J., Wang Q., Williams G.A., Wong G.K.-S., Yao Z., Zhang J., Zhang X., RA Zhao G., Zhou J., Zhou Y., Nelson D., Lehrach H., Reinhardt R., RA Naylor S.L., Yang H., Olson M., Weinstock G., Gibbs R.A.; RT "The DNA sequence, annotation and analysis of human chromosome 3."; RL Nature 440:1194-1198(2006). RN [2] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RA Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M., RA Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J., RA Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S., RA Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H., RA Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K., RA Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D., RA Hunkapiller M.W., Myers E.W., Venter J.C.; RL Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases. RN [3] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 107-286. RC TISSUE=Hepatoma; RX PubMed=14702039; DOI=10.1038/ng1285; RA Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R., RA Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H., RA Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S., RA Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K., RA Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H., RA Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M., RA Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K., RA Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T., RA Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M., RA Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S., RA Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H., RA Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K., RA Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N., RA Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S., RA Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O., RA Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H., RA Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B., RA Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y., RA Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K., RA Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T., RA Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T., RA Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y., RA Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H., RA Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y., RA Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H., RA Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O., RA Isogai T., Sugano S.; RT "Complete sequencing and characterization of 21,243 full-length human RT cDNAs."; RL Nat. Genet. 36:40-45(2004). RN [4] RP NOMENCLATURE, AND IDENTIFICATION. RX PubMed=15520277; DOI=10.1101/gad.1255304; RA Jin J., Cardozo T., Lovering R.C., Elledge S.J., Pagano M., Harper J.W.; RT "Systematic analysis and nomenclature of mammalian F-box proteins."; RL Genes Dev. 18:2573-2580(2004). RN [5] RP ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR RP METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS SPECTROMETRY RP [LARGE SCALE ANALYSIS]. RX PubMed=19413330; DOI=10.1021/ac9004309; RA Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S.; RT "Lys-N and trypsin cover complementary parts of the phosphoproteome in a RT refined SCX-based approach."; RL Anal. Chem. 81:4493-4501(2009). RN [6] RP FUNCTION, AND INDUCTION. RX PubMed=19581926; DOI=10.1038/onc.2009.177; RA Peschiaroli A., Scialpi F., Bernassola F., Pagano M., Melino G.; RT "The F-box protein FBXO45 promotes the proteasome-dependent degradation of RT p73."; RL Oncogene 28:3157-3166(2009). RN [7] RP IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RX PubMed=21269460; DOI=10.1186/1752-0509-5-17; RA Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T., RA Bennett K.L., Superti-Furga G., Colinge J.; RT "Initial characterization of the human central proteome."; RL BMC Syst. Biol. 5:17-17(2011). RN [8] RP INTERACTION WITH HEY1, AND SUBCELLULAR LOCATION. RX PubMed=26068074; DOI=10.1371/journal.pone.0130288; RA Salat D., Winkler A., Urlaub H., Gessler M.; RT "Hey bHLH Proteins Interact with a FBXO45 Containing SCF Ubiquitin Ligase RT Complex and Induce Its Translocation into the Nucleus."; RL PLoS ONE 10:e0130288-e0130288(2015). RN [9] RP FUNCTION, AND INTERACTION WITH MYCBP2 AND SKP1. RX PubMed=29997255; DOI=10.1074/jbc.ra118.002176; RA Desbois M., Crawley O., Evans P.R., Baker S.T., Masuho I., Yasuda R., RA Grill B.; RT "PAM forms an atypical SCF ubiquitin ligase complex that ubiquitinates and RT degrades NMNAT2."; RL J. Biol. Chem. 293:13897-13909(2018). RN [10] RP FUNCTION. RX PubMed=31285543; DOI=10.1038/s41418-019-0385-7; RA Richter K.T., Kschonsak Y.T., Vodicska B., Hoffmann I.; RT "FBXO45-MYCBP2 regulates mitotic cell fate by targeting FBXW7 for RT degradation."; RL Cell Death Differ. 27:758-772(2020). RN [11] RP FUNCTION, AND INDUCTION BY INFLUENZA INFECTION. RX PubMed=36379255; DOI=10.1016/j.jbc.2022.102698; RA Tsai M., Osman W., Adair J., ElMergawy R., Chafin L., Johns F., Farkas D., RA Elhance A., Londino J., Mallampalli R.K.; RT "The E3 ligase subunit FBXO45 binds the interferon-lambda receptor and RT promotes its degradation during influenza virus infection."; RL J. Biol. Chem. 298:102698-102698(2022). RN [12] RP INTERACTION WITH CDH2, AND SUBCELLULAR LOCATION. RX PubMed=32341084; DOI=10.1128/mcb.00539-19; RA Na Y., Calvo-Jimenez E., Kon E., Cao H., Jossin Y., Cooper J.A.; RT "Fbxo45 Binds SPRY Motifs in the Extracellular Domain of N-Cadherin and RT Regulates Neuron Migration during Brain Development."; RL Mol. Cell. Biol. 40:0-0(2020). CC -!- FUNCTION: Component of E3 ubiquitin ligase complex consisting of CC FBXO45, MYCBP2 and SKP1 (PubMed:29997255). Functions in substrate CC recognition but plays also an important role in assembly of the complex CC (PubMed:29997255). Required for normal neuromuscular synaptogenesis, CC axon pathfinding and neuronal migration (By similarity). Regulates CC neuron migration during brain development through interaction with N- CC cadherin/CDH2 after secretion via a non-classical mechanism (By CC similarity). Plays a role in the regulation of neurotransmission at CC mature neurons (By similarity). May control synaptic activity by CC controlling UNC13A via ubiquitin dependent pathway (By similarity). CC Specifically recognizes TP73, promoting its ubiquitination and CC degradation. Polyubiquitinates NMNAT2, an adenylyltransferase that acts CC as an axon maintenance factor, and regulates its stability and CC degradation by the proteasome (PubMed:29997255). Acts also by CC ubiquitinating FBXW7 during prolonged mitotic arrest and promotes FBXW7 CC proteasomal degradation (PubMed:31285543). Induces subsequently an CC increase in mitotic slippage and prevents mitotic cell death CC (PubMed:31285543). In response to influenza infection, mediates CC interferon-lambda receptor IFNLR1 polyubiquitination and degradation CC through the ubiquitin-proteasome system by docking with its CC intracellular receptor domain (PubMed:36379255). CC {ECO:0000250|UniProtKB:P0CH38, ECO:0000250|UniProtKB:Q8K3B1, CC ECO:0000269|PubMed:19581926, ECO:0000269|PubMed:29997255, CC ECO:0000269|PubMed:31285543, ECO:0000269|PubMed:36379255}. CC -!- PATHWAY: Protein modification; protein ubiquitination. CC -!- SUBUNIT: Forms a complex with MYCBP2 and SKP1 (PubMed:29997255). CC Interacts with HEY1; leading to FBXO45 nuclear translocation. Interacts CC (via SPRY domain) with CDH2 (PubMed:32341084). CC {ECO:0000269|PubMed:19581926, ECO:0000269|PubMed:32341084}. CC -!- SUBCELLULAR LOCATION: Secreted {ECO:0000269|PubMed:32341084}. CC Postsynaptic cell membrane {ECO:0000250|UniProtKB:P0CH38}. Presynaptic CC cell membrane {ECO:0000250|UniProtKB:P0CH38}. Nucleus CC {ECO:0000269|PubMed:26068074}. Note=Secreted by a non-classical CC mechanism. {ECO:0000269|PubMed:32341084}. CC -!- INDUCTION: Down-regulated in response to DNA-damage (PubMed:19581926). CC Induced upon influenza infection (PubMed:36379255). CC {ECO:0000269|PubMed:19581926, ECO:0000269|PubMed:36379255}. CC -!- SIMILARITY: Belongs to the FBXO45/Fsn family. {ECO:0000305}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; AC092933; -; NOT_ANNOTATED_CDS; Genomic_DNA. DR EMBL; CH471191; EAW53643.1; -; Genomic_DNA. DR EMBL; CH471191; EAW53644.1; -; Genomic_DNA. DR EMBL; AK025697; -; NOT_ANNOTATED_CDS; mRNA. DR CCDS; CCDS46985.1; -. DR RefSeq; NP_001099043.1; NM_001105573.1. DR AlphaFoldDB; P0C2W1; -. DR SMR; P0C2W1; -. DR BioGRID; 128358; 194. DR ComplexPortal; CPX-8004; Non-canonical FBXO45-MYCBP2-SKP1 E3 ubiquitin ligase complex. DR IntAct; P0C2W1; 61. DR STRING; 9606.ENSP00000310332; -. DR GlyGen; P0C2W1; 1 site, 1 O-linked glycan (1 site). DR iPTMnet; P0C2W1; -. DR PhosphoSitePlus; P0C2W1; -. DR BioMuta; FBXO45; -. DR DMDM; 146286173; -. DR jPOST; P0C2W1; -. DR MassIVE; P0C2W1; -. DR PaxDb; 9606-ENSP00000310332; -. DR PeptideAtlas; P0C2W1; -. DR ProteomicsDB; 52305; -. DR Pumba; P0C2W1; -. DR Antibodypedia; 51201; 91 antibodies from 16 providers. DR DNASU; 200933; -. DR Ensembl; ENST00000311630.7; ENSP00000310332.6; ENSG00000174013.8. DR GeneID; 200933; -. DR KEGG; hsa:200933; -. DR MANE-Select; ENST00000311630.7; ENSP00000310332.6; NM_001105573.2; NP_001099043.1. DR UCSC; uc010iai.4; human. DR AGR; HGNC:29148; -. DR CTD; 200933; -. DR DisGeNET; 200933; -. DR GeneCards; FBXO45; -. DR HGNC; HGNC:29148; FBXO45. DR HPA; ENSG00000174013; Low tissue specificity. DR MIM; 609112; gene. DR neXtProt; NX_P0C2W1; -. DR OpenTargets; ENSG00000174013; -. DR PharmGKB; PA134904114; -. DR VEuPathDB; HostDB:ENSG00000174013; -. DR eggNOG; KOG3953; Eukaryota. DR GeneTree; ENSGT01030000234629; -. DR HOGENOM; CLU_046756_1_0_1; -. DR InParanoid; P0C2W1; -. DR OMA; ATKRASM; -. DR OrthoDB; 2398163at2759; -. DR PhylomeDB; P0C2W1; -. DR TreeFam; TF312822; -. DR PathwayCommons; P0C2W1; -. DR SignaLink; P0C2W1; -. DR SIGNOR; P0C2W1; -. DR UniPathway; UPA00143; -. DR BioGRID-ORCS; 200933; 9 hits in 1187 CRISPR screens. DR ChiTaRS; FBXO45; human. DR GenomeRNAi; 200933; -. DR Pharos; P0C2W1; Tbio. DR PRO; PR:P0C2W1; -. DR Proteomes; UP000005640; Chromosome 3. DR RNAct; P0C2W1; protein. DR Bgee; ENSG00000174013; Expressed in secondary oocyte and 194 other cell types or tissues. DR ExpressionAtlas; P0C2W1; baseline and differential. DR GO; GO:0042995; C:cell projection; IEA:UniProtKB-KW. DR GO; GO:0005737; C:cytoplasm; IC:UniProt. DR GO; GO:0005576; C:extracellular region; IEA:UniProtKB-SubCell. DR GO; GO:0098978; C:glutamatergic synapse; IEA:Ensembl. DR GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell. DR GO; GO:0099524; C:postsynaptic cytosol; IEA:Ensembl. DR GO; GO:0014069; C:postsynaptic density; IEA:Ensembl. DR GO; GO:0045211; C:postsynaptic membrane; IEA:UniProtKB-SubCell. DR GO; GO:0099523; C:presynaptic cytosol; IEA:Ensembl. DR GO; GO:0042734; C:presynaptic membrane; IEA:UniProtKB-SubCell. DR GO; GO:0019005; C:SCF ubiquitin ligase complex; IBA:GO_Central. DR GO; GO:0045202; C:synapse; IBA:GO_Central. DR GO; GO:1990756; F:ubiquitin-like ligase-substrate adaptor activity; IDA:UniProt. DR GO; GO:0021960; P:anterior commissure morphogenesis; IEA:Ensembl. DR GO; GO:0021799; P:cerebral cortex radially oriented cell migration; IEA:Ensembl. DR GO; GO:0021800; P:cerebral cortex tangential migration; IEA:Ensembl. DR GO; GO:0021957; P:corticospinal tract morphogenesis; IEA:Ensembl. DR GO; GO:0006974; P:DNA damage response; IDA:UniProtKB. DR GO; GO:0001764; P:neuron migration; IEA:Ensembl. DR GO; GO:0043161; P:proteasome-mediated ubiquitin-dependent protein catabolic process; ISS:UniProtKB. DR GO; GO:0070936; P:protein K48-linked ubiquitination; IDA:UniProt. DR GO; GO:0016567; P:protein ubiquitination; IDA:UniProtKB. DR GO; GO:2000300; P:regulation of synaptic vesicle exocytosis; IEA:Ensembl. DR GO; GO:0060386; P:synapse assembly involved in innervation; IBA:GO_Central. DR GO; GO:0006511; P:ubiquitin-dependent protein catabolic process; IDA:UniProtKB. DR CDD; cd22111; F-box_FBXO45; 1. DR CDD; cd12907; SPRY_Fbox; 1. DR FunFam; 1.20.1280.50:FF:000024; F-box/SPRY domain-containing protein 1; 1. DR FunFam; 2.60.120.920:FF:000017; F-box/SPRY domain-containing protein 1; 1. DR Gene3D; 1.20.1280.50; -; 1. DR Gene3D; 2.60.120.920; -; 1. DR InterPro; IPR001870; B30.2/SPRY. DR InterPro; IPR043136; B30.2/SPRY_sf. DR InterPro; IPR013320; ConA-like_dom_sf. DR InterPro; IPR036047; F-box-like_dom_sf. DR InterPro; IPR001810; F-box_dom. DR InterPro; IPR050672; FBXO45-Fsn/SPSB_families. DR InterPro; IPR003877; SPRY_dom. DR InterPro; IPR035784; SPRY_FBXO45. DR PANTHER; PTHR12245:SF7; F-BOX_SPRY DOMAIN-CONTAINING PROTEIN 1; 1. DR PANTHER; PTHR12245; SPRY DOMAIN CONTAINING SOCS BOX PROTEIN; 1. DR Pfam; PF12937; F-box-like; 1. DR Pfam; PF00622; SPRY; 1. DR SMART; SM00256; FBOX; 1. DR SMART; SM00449; SPRY; 1. DR SUPFAM; SSF49899; Concanavalin A-like lectins/glucanases; 1. DR SUPFAM; SSF81383; F-box domain; 1. DR PROSITE; PS50188; B302_SPRY; 1. DR PROSITE; PS50181; FBOX; 1. PE 1: Evidence at protein level; KW Acetylation; Cell membrane; Cell projection; Developmental protein; KW Membrane; Neurogenesis; Nucleus; Postsynaptic cell membrane; KW Proteomics identification; Reference proteome; Secreted; Synapse; KW Ubl conjugation pathway. FT INIT_MET 1 FT /note="Removed" FT /evidence="ECO:0007744|PubMed:19413330" FT CHAIN 2..286 FT /note="F-box/SPRY domain-containing protein 1" FT /id="PRO_0000285933" FT DOMAIN 33..82 FT /note="F-box" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00080" FT DOMAIN 92..284 FT /note="B30.2/SPRY" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00548" FT MOD_RES 2 FT /note="N-acetylalanine" FT /evidence="ECO:0007744|PubMed:19413330" SQ SEQUENCE 286 AA; 30633 MW; C2CF11ED007CC837 CRC64; MAAPAPGAGA ASGGAGCSGG GAGAGAGSGS GAAGAGGRLP SRVLELVFSY LELSELRSCA LVCKHWYRCL HGDENSEVWR SLCARSLAEE ALRTDILCNL PSYKAKIRAF QHAFSTNDCS RNVYIKKNGF TLHRNPIAQS TDGARTKIGF SEGRHAWEVW WEGPLGTVAV IGIATKRAPM QCQGYVALLG SDDQSWGWNL VDNNLLHNGE VNGSFPQCNN APKYQIGERI RVILDMEDKT LAFERGYEFL GVAFRGLPKV CLYPAVSAVY GNTEVTLVYL GKPLDG //